The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Self-Assembled Redox Dual-Responsive Prodrug-Nanosystem Formed by Single Thioether-Bridged Paclitaxel-Fatty Acid Conjugate for Cancer Chemotherapy
Open accessAbstract
Chemotherapeutic efficacy can be greatly improved by developing nanoparticulate drug delivery systems (nano-DDS) with high drug loading capacity and smart stimulus-triggered drug release in tumor cells. Herein, we report a novel redox dual-responsive prodrug-nanosystem self-assembled by hydrophobic small-molecule conjugates of paclitaxel (PTX) and oleic acid (OA). Thioether linked conjugates (PTX-S-OA) and dithioether inserted conjugates (PTX-2S-OA) are designed to respond to the redox-heterogeneity in tumor. Dithioether has been reported to show redox dual-responsiveness, but we find that PTX-S-OA exhibits superior redox sensitivity over PTX-2S-OA, achieving more rapid and selective release of free PTX from the prodrug nanoassemblies triggered by redox stimuli. PEGylated PTX-S-OA nanoassemblies, with impressively high drug loading (57.4%), exhibit potent antitumor activity in a human epidermoid carcinoma xenograft. This novel prodrug-nanosystem addresses concerns related to the low drug loading and inefficient drug release from hydrophobic prodrugs of PTX, and provides possibilities for the development of redox dual-sensitive conjugates or polymers for efficient anticancer drug delivery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanotechnology in Drug Delivery and Tissue Engineering: From Discovery to Applications
Shi, J., Votruba, A. R., Farokhzad, O. C., & Langer, R. (2010) · Nano Letters · doi:10.1021/nl102184c · Cited by 1,612
Tumor heterogeneity: Causes and consequences
Marusyk, A., & Polyak, K. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.11.002 · Cited by 1,602
Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems
Karimi, M., Ghasemi, A., Sahandi Zangabad, P., Rahighi, R., Moosavi Basri, S. M., Mirshekari, H., Amiri, M., Shafaei Pishabad, Z., Aslani, A., Bozorgomid, M., et al. (2016) · Chemical Society Reviews · doi:10.1039/c5cs00798d · Cited by 1,519
Welt, F. G. P., & Edelman, E. R. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)90003-x · Cited by 863
Therapeutic strategies by modulating oxygen stress in cancer and inflammation
Fang, J., Seki, T., & Maeda, H. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.02.005 · Cited by 544
Tumor Redox Heterogeneity‐Responsive Prodrug Nanocapsules for Cancer Chemotherapy
Wang, J., Sun, X., Mao, W., Sun, W., Tang, J., Sui, M., Shen, Y., & Gu, Z. (2013) · Advanced Materials · doi:10.1002/adma.201300929 · Cited by 395
Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor
Yin, Q., Shen, J., Zhang, Z., Yu, H., & Li, Y. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.04.011 · Cited by 365
Prodrug-based nanoparticulate drug delivery strategies for cancer therapy
Luo, C., Sun, J., Sun, B., & He, Z. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.09.008 · Cited by 352
Self-citationProdrug-based intracellular delivery of anticancer agents
Bildstein, L., Dubernet, C., & Couvreur, P. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.12.005 · Cited by 310
Wang, Y., Liu, D., Zheng, Q., Zhao, Q., Zhang, H., Ma, Y., Fallon, J. K., Fu, Q., Haynes, M. T., Lin, G., et al. (2014) · Nano Letters · doi:10.1021/nl502044x · Cited by 252
Self-citationPaclitaxel drug delivery systems
Zhang, Z., Mei, L., & Feng, S.-S. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.752354 · Cited by 182
Tumor targeting by covalent conjugation of a natural fatty acid to paclitaxel.
Bradley, M. O., Webb, N. L., Anthony, F. H., Devanesan, P. D., Witman, P. A., Hemamalini, S., Chander, M. C., Baker, S. D., He, L., Horwitz, S. B., et al. (2001) · PubMed · Cited by 180
Nanotechnology in cancer therapy
Aslan, B., Ozpolat, B., Sood, A. K., & Lopez-Berestein, G. (2013) · Journal of Drug Targeting · doi:10.3109/1061186x.2013.837469 · Cited by 180
Redox metabolism and malignancy
Grek, C. L., & Tew, K. D. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.05.003 · Cited by 160
Xiao, C., Ding, J., Ma, L., Yang, C., Zhuang, X., & Chen, X. (2014) · Polymer Chemistry · doi:10.1039/c4py01156b · Cited by 115
Superoxide generation by the respiratory chain of tumor mitochondria
Konstantinov, A. A., Peskin, A. V., Popova, E. Y., Khomutov, G. B., & Ruuge, E. K. (1987) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(87)90206-4 · Cited by 109
Du, X., Wang, J., Liu, W.-W., Yang, J., Sun, C., Sun, R., Li, H.-J., Shen, S., Luo, Y., Xiao-dong, Y., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.07.048 · Cited by 107
Heterogeneity of glutathione content in human ovarian cancer.
Lee, F. Y., Vessey, A. R., Rofstad, E. K., Siemann, D. W., & Sutherland, R. M. (1989) · PubMed · Cited by 92
Wolff, A. C., Donehower, R. C., Carducci, M., Carducci, M. A., Brahmer, J. R., Zabelina, Y., Bradley, M. O., Anthony, F. H., Swindell, C. S., Witman, P. A., et al. (2003) · PubMed · Cited by 80
The therapeutic efficacy of conjugated linoleic acid – Paclitaxel on glioma in the rat
Ke, X., Zhao, B., Zhao, X., Wang, Y., Huang, Y. M., Chen, X.-M., Zhao, B., Zhao, S., Zhang, X. K., & Zhang, Q. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.03.079 · Cited by 78
Caron, J., Maksimenko, A., Wack, S., Lepeltier, É., Bourgaux, C., Morvan, E., Leblanc, K., Couvreur, P., & Desmaële, D. (2012) · Advanced Healthcare Materials · doi:10.1002/adhm.201200099 · Cited by 72
Advances of Paclitaxel Formulations Based on Nanosystem Delivery Technology
Luo, C., Wang, Y., Chen, Q., Han, X., Liu, X., Sun, J., & He, Z. (2012) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955712800493924 · Cited by 55
Self-citationNovel Isoprenoyl Nanoassembled Prodrug for Paclitaxel Delivery
Mura, S., Zouhiri, F., Lerondel, S., Maksimenko, A., Mougin, J., Gueutin, C., Brambilla, D., Caron, J., Śliwiński, É., Pape, A. L., et al. (2013) · Bioconjugate Chemistry · doi:10.1021/bc400210x · Cited by 51
Harries, M., O’Donnell, A. E., Scurr, M. R., Reade, S., Cole, C., Judson, I. R., Greystoke, A., Twelves, C. J., & Kaye, S. B. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602196 · Cited by 27
Cited by
Polymer–drug conjugate therapeutics: advances, insights and prospects
Ekladious, I., Colson, Y. L., & Grinstaff, M. W. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0005-0 · Cited by 855
Recent progress in drug delivery
Li, C., Wang, J., Wang, Y., Gao, H., Wei, G., Huang, Y., Yu, H., Gan, Y., Wang, Y., Mei, L., et al. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.08.003 · Cited by 818
Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment
Liu, R., Luo, C., Pang, Z., Zhang, J., Ruan, S., Wu, M., Wang, L., Sun, T., Li, N., Han, L., et al. (2023) · Chinese Chemical Letters · doi:10.1016/j.cclet.2022.05.032 · Cited by 516
Self-citationTheranostic Fluorescent Probes
Sharma, A., Verwilst, P., Li, M., Ma, D., Singh, N., Yoo, J., Kim, Y., Yang, Y., Zhu, J.-H., Huang, H., et al. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00778 · Cited by 499
Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy
Sun, B., Luo, C., Yu, H., Zhang, X., Chen, Q., Yang, W., Wang, M., Kan, Q., Zhang, H., Wang, Y., et al. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b00737 · Cited by 426
Self-citation
Metadata
- Authors
- Luo, C., Sun, J., Liu, D., Sun, B., Miao, L., Musetti, S., Li, J., Han, X., Du, Y., Li, L., Huang, L., & He, Z.
- Venue
- Nano Letters
- Publisher
- American Chemical Society (ACS)
- Published
- 2016-08-08
- Volume
- 16
- Issue
- 9
- Pages
- 5401-5408
- ISSN
- 1530-6984 (ISSN-L)
- 1530-6992
- OpenAlex
- W2503470809
- Cited by
- 443
- References
- 24
- FWCI
- 15.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.